This topic contains a solution. Click here to go to the answer

Author Question: A patient who has recently begun taking carbamazepine Equetro for bipolar disorder reports having ... (Read 20 times)

elizabeth18

  • Hero Member
  • *****
  • Posts: 559
A patient who has recently begun taking carbamazepine Equetro for bipolar disorder reports having vertigo and headaches. Which action by the nurse is appropriate?
 
  a. Ask the provider whether another medica-tion can be used for this patient, because the patient is showing signs of toxicity.
  b. Contact the provider to request a complete blood count (CBC) to evaluate for other, more serious side effects.
  c. Reassure the patient that these effects oc-cur early in treatment and will resolve over time.
  d. Review the patient's chart for cytochrome P450 enzymes to see whether an increased dose is needed.

Question 2

A patient with Parkinson's disease is taking levodopa/carbidopa Sinemet along with amanta-dine Symmetrel 400 mg/day to treat dyskinesias. The patient reports having increased dyskine-sias several months after beginning the amantadine.
 
  The nurse will contact the provider to discuss which action? a. Increasing the dose of amantadine Sym-metrel
  b. Interrupting treatment with amantadine for several weeks
  c. Ordering renal function tests
  d. Ordering another anticholinergic medica-tion



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

skipfourms123

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

C
Carbamazepine can cause several neurologic side effects early in treatment, including vertigo and headaches. These resolve with continued drug use. These side effects are not related to drug toxicity. A CBC should be obtained at baseline and periodically thereafter. Carbamazepine can cause changes in hematologic laboratory values. The side effects reported by this patient are not associated with hematologic side effects. Carbamazepine induces cytochrome P450 enzymes and can accelerate its own metabolism, which would reduce the amount of drug and decrease side effects, so an increased dose is not appropriate.

Answer to Question 2

B
When amantadine is added to therapy to treat dyskinesias associated with levodopa, it often loses effectiveness after several months. If the effects diminish, they can be restored by either increasing the dosage or by interrupting treatment for several weeks. The maximum dosage of amantadine is 400 mg/day, so it is incorrect to increase the dose. Altered renal function would result in drug toxicity, not ineffectiveness of the drug. It is not necessary to order another drug until determining whether the effectiveness can be restored.




elizabeth18

  • Member
  • Posts: 559
Reply 2 on: Jul 23, 2018
Gracias!


kishoreddi

  • Member
  • Posts: 329
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

To combat osteoporosis, changes in lifestyle and diet are recommended. At-risk patients should include 1,200 to 1,500 mg of calcium daily either via dietary means or with supplements.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

For a complete list of videos, visit our video library